Authors
Loading...
Metabolomic profiling demonstrates anti-TNF remission prediction in inflammatory bowel disease, highlighting gut microbial metabolism as a therapeutic biomarker.
Aden et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: